Three leading AI scale-ups – Aidence, ScreenPoint Medical and Thirona – have launched the informative video series “Opening the black box of AI in medical imaging”. Their aim is to close knowledge gaps and increase trust in imaging AI by explaining how this emerging technology can be applied in radiology. The collaboration is unique in the industry.
Solving the “black box” problem
Artificial intelligence is referred to as a “black box” because its inputs and outputs are visible, but not the workings in-between. It is often the cause of public distrust and lack of acceptance.
A recent survey of over 1,000 radiologists and radiology residents found that the more radiologists know about AI, the more likely they are to adopt it rather than fear replacement.
As front-runners in the MedTech industry, Aidence, ScreenPoint Medical and Thirona recognise their role in making AI comprehensible to healthcare professionals. They decided to bring their complementary insights together and answer frequent questions on AI in an innovative way.
One episode at a time
Each episode of “Opening the Black Box” covers one specific topic related to AI in medical imaging in approximately 10 minutes. The videos use a combination of animations and interviews with clinical, data science, regulatory, and industry experts.
The series starts with the basics: a short history of AI and how it differs from machine and deep learning. Mark-Jan Harte, Eva van Rikxoort and Nico Karssemeijer, founders of the three companies, explain what AI means to them. Watch the first episode here: https://www.blackboxmed.ai/.
Future episodes will address the benefits of AI for medical imaging and the development, validation, and certification of AI algorithms for automated image analysis. The series will also show real-world examples of AI deployments and applications in, for example, early breast and lung cancer detection.
Episodes will be made available here over the coming months: https://www.blackboxmed.ai/.
Aidence was founded in November 2015 by Mark-Jan Harte and Jeroen van Duffelen. Based in the Netherlands and the UK, Aidence rallies over 50 data scientists, medical and regulatory professionals, and software engineers to provide intelligent software for the oncology pathway. Aidence’s first clinical application is Veye Lung Nodules, an AI-based solution for pulmonary nodule management on chest CTs. Veye Lung Nodules is currently running in routine practice and lung cancer screening programmes across Europe, analysing thousands of patients scans each week.
About ScreenPoint Medical
ScreenPoint Medical was founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady. They are a leading developer of AI driven image analysis technology which enables the automated reading of mammograms and digital breast tomosynthesis examinations. With their Transpara system, ScreenPoint Medical is focused on helping to improve breast cancer survival rates by detecting cancers earlier so that treatment can be more effective and less invasive.
Thirona is an innovative Dutch company specialised in artificial intelligence for medical image analysis. By creating intuitive and user-friendly products, it bridges the gap between academic ideas and clinical use. Thirona supports medical professionals in their daily tasks working with thoracic CT-scans (LungQTM), chest X-rays (CAD4TBTM) and retinal scans (RetCADTM). A start-up in 2014, Thirona has grown to become an important player in the medical field, with innovative AI-solutions used in over forty countries worldwide.